[DOI] [PMC free article] [PubMed] [Google Scholar] 182.Ling C.H.Y., de Craen A.J.M., Slagboom P.E., Gunn D.A., Stokkel M.P.M., Westendorp R.G.J., Maier A.B
Specifically, GLP-1 use was associated with an 18% lower risk of a composite TED-related diagnosis at one year and a 10% lower risk at three years. This retrospective, population-based cohort study used the TriNetX US Collaborative Network to identify patients with thyroid disease initiating a GLP-1 drug or a non-GLP-1 active control medication
Zepbound does not weaken the immune system, so it does not increase the chance of infection
Increased energy levels also boost your self-confidence, enabling you to make the best of your new fit body
Canakinumab (Ilaris): See above
Why You Might Be Here If your weekly GLP-1 injection leaves you nauseous, exhausted, or unsure what to eat, youre not alone